CSUI.US Cannabis Suisse Corp
- Market cap
- USD 544K
- P/E
- -
- P/B
- 1,747.40x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.
Is CSUI.US undervalued?
Graham numberThe Graham number of Cannabis Suisse Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cannabis Suisse Corp fundamental analysis
No fundamental analysis for Cannabis Suisse Corp yet.
Cannabis Suisse Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cannabis Suisse Corp
Cannabis Suisse Corp. engages in the real estate business. It leases commercial office and industrial space. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Jacksonville, Florida.
Full company profileCannabis Suisse Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cannabis Suisse Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 14.2K | 6.50K | 7.53K | 243K | 50.9K | 7.77K | 10.0K | 30.0K | 22.5K | 21.0K | 84.0K |
| Gross Profit | 10.3K | 4.20K | 4.99K | -84.8K | -51.8K | 6.04K | 834.00 | -67.00 | 432.00 | 16.8K | 79.8K |
| Operating Income | -26.7K | -16.4K | -22.7K | -351K | -358K | -157K | -343K | -257K | -284K | -268K | -173K |
| EBITDA | -24.1K | -9.53K | -17.2K | -369K | -329K | -122K | -338K | -1.16M | -284K | -264K | -169K |
| Net Income | -26.7K | -16.4K | -22.7K | -389K | -411K | -188K | -352K | -1.27M | -456K | 123K | 221K |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 38.2K | 28.2K | 333K | 384K | 6.57K | 0.00 | 346K | 819K | 635K | 407K | 359K |
| Total Liabilities | 29.1K | 35.5K | 313K | 770K | 194K | 274K | 676K | 2.24M | 2.44M | 2.09M | 1.98M |
| Shareholders' Equity | 9.09K | -7.33K | 19.9K | -387K | -187K | -274K | -329K | -1.42M | -1.80M | -1.68M | -1.62M |
| Cash & Short-term Investments | 6.19K | 6.19K | 84.2K | 5.00 | 0.00 | - | -207K | 28.6K | 2.85K | 476.00 | 256.00 |
| Total Debt | - | - | 3.62K | 188K | 67.2K | 135K | 477K | 2.12M | 2.35M | 1.90M | 1.78M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -32.2K | -6.40K | -11.9K | -289K | -131K | -32.1K | -164K | -45.6K | -45.1K | -40.3K | 51.1K |
| Capital Expenditure | 22.9K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -55.1K | -6.40K | -11.9K | -289K | -131K | -32.1K | -164K | -45.6K | -45.1K | -40.3K | 51.1K |
| Ratios | |||||||||||
| ROE | -293.4% | - | -114.0% | - | - | - | - | - | - | - | - |
| ROA | -69.8% | -58.3% | -6.8% | -101.4% | -6,258.6% | - | -101.5% | -154.5% | -71.8% | 30.1% | 61.4% |
| Net Profit Margin | -187.9% | -252.6% | -301.8% | -160.3% | -808.3% | -2,418.1% | -3,515.5% | -4,216.7% | -2,027.3% | 584.5% | 262.5% |
| Debt to Equity | - | - | 0.18x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cannabis Suisse Corp dividends
Cannabis Suisse Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 20:1 on Feb 28, 2019.
Who owns Cannabis Suisse Corp
- Insiders 51.47%
- Institutions 0.00%
- Public & others 48.54%
- Shares outstanding 70.7M
- Free float 34.3M
Cannabis Suisse Corp company profile
- Company name
- Cannabis Suisse Corp
- Ticker
- CSUI.US
- Exchange
- USA Stocks
- Sector
- Real Estate
- Industry
- Pharmaceuticals
- Fiscal year end
- May
- Address
- 10 North Newnan Street, Jacksonville, FL, United States, 32202
- Phone
- 904 595 5820
- Website
- cannabissuissecorp.com
About Cannabis Suisse Corp
Cannabis Suisse Corp. engages in the real estate business. It leases commercial office and industrial space. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Jacksonville, Florida.
Cannabis Suisse Corp management
1- Mr. Scott W. McalisterCEO, CFO & Director · born 1981